<DOC>
	<DOCNO>NCT02146040</DOCNO>
	<brief_summary>The aim study evaluate role atrial fibrillation ( AF ) treatment relation thromboembolic event ( stroke , transient ischemic attack ) intracranial hemorrhage . Primary Outcome Measures : - Incidence time intracranial complication ( stroke , TIA , bleeding ) relation diagnosis anticoagulation treatment AF study period ; comparison complication without anticoagulation treatment accord CHADSVASc score . Secondary Outcome Measures : - The effect anticoagulation pause INR level stroke bleed risk ; stroke within 30 day anticoagulation pause prevalence stroke intracranila bleed relation INR level &lt; 2 , 2-3 &gt; 3 . - Trauma risk factor intracranial bleeding : percentage risk factor intracranial bleed without trauma . Type precede trauma type intracranial bleeding . - The time relation diagnosis AF type intracranial complication : Kaplan Meier analysis thrombotic ( Stroke/TIA ) intracranial bleeding complication 1st diagnosis AF patient without anticoagulation - The risk stroke intracranial bleeding relation CHADSVASc score , HAS-BLED score anticoagulation/antithrombotic treatment - Prognosis stroke intracranial bleeding : 30-day mortality stroke intracerebral bleeding patient without anticoagulation - Factors related underuse anticoagulation treatment . Data reason start stop aticoagulation indication oral anticoagulation - Operations procedure risk factor stroke : Frequency type operation perform &lt; 30 day stroke . Data length perioperative pause anticoagulation use bridge therapy timiing stroke collect . - Cardioversions risk factor stroke : Frequency stroke TIA &lt; 30 day cardioversion relation use anticoagulation CHADSVASc score - The risk stroke intracranial bleeding relation type AF ( permanent , persistent , paroxysmal ) concomitant carotid disease Estimated Enrollment : 6000 patient .</brief_summary>
	<brief_title>Atrial Fibrillation Cause Stroke Intracranial Hemorrhage Study ( The FibStroke Study )</brief_title>
	<detailed_description>Approximately 20 % stroke cause atrial fibrillation ( AF ) 1 % patient AF suffer intracranial hemorrhage . Thus , net benefit AF management key factor choose successful treatment ( pharmacological interventional ) . In retrospective Finnish multicenter study investigator collect data patient intracranial thromboembolic event intracranial hemorrhage AF study period . All patient â‰¥18 year age identify relevant clinical detail retrospectively gather hospital record participate hospital internet-based CRF . The total study period 2003 2012 . All case record review use standardize data collection protocol get information baseline characteristic medication patient , management patient index complication 30-day follow-up complication . Diagnosis atrial fibrillation base 12-lead electrocardiography accord standard criterion . Stroke document clinically confirm computerized tomography magnetic resonance imaging cause cerebral infarction . Diagnosis transient ischemic attack base clinical diagnosis neurologist stroke confirmed imaging . After completion manual registration data , computer-based cross-checking stroke perform discharge register data include patient ensure complete coverage event . Diagnosis inctracranial bleeding base patient record classify subdural , subarachnoidal intracerebral possible precede trauma register . Outcome measure classify study neurologist necessary . Antigoagulation treatment , INR level index complication , possible pause treatment casues register togethr information antiplatelet treatment .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Ischemic Attack , Transient</mesh_term>
	<mesh_term>Intracranial Hemorrhages</mesh_term>
	<criteria>All patient age 18 , hospitalize emergency unit visit study period thromboembolic event ( stroke , TIA ) intracranial hemorrhage diagnosis atrial fibrillation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>anticoagulation</keyword>
	<keyword>atrial fibrillation</keyword>
	<keyword>cardioversion</keyword>
	<keyword>complication</keyword>
	<keyword>hemorrhage</keyword>
	<keyword>medication</keyword>
	<keyword>thromboembolism</keyword>
	<keyword>TIA</keyword>
	<keyword>stroke</keyword>
	<keyword>treatment</keyword>
</DOC>